Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancerBOZIONELLOU, Vassiliki; MAVROUDIS, Dimitris; PERRAKI, Maria et al.Clinical cancer research. 2004, Vol 10, Num 24, pp 8185-8194, issn 1078-0432, 10 p.Article

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler systemSTATHOPOULOU, Aliki; GIZI, Anna; PERRAKI, Maria et al.Clinical cancer research. 2003, Vol 9, Num 14, pp 5145-5151, issn 1078-0432, 7 p.Article

Development of a highly sensitive RT-PCR luminometric hybridization assay for human telomerase reverse-transcriptase beta-plus transcriptANGELOPOULOU, Katerina; SPIROPOULOU, Tonia; STATHOPOULOU, Aliki et al.Anticancer research. 2003, Vol 23, Num 6C, pp 4821-4829, issn 0250-7005, 9 p.Article

Different Prognostic Value of Cytokeratin-19 mRNA-Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast CancerIGNATIADIS, Michail; XENIDIS, Nikos; SOTIRIOU, Christos et al.Journal of clinical oncology. 2007, Vol 25, Num 33, pp 5194-5202, issn 0732-183X, 9 p.Article

Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patientsXENIDIS, Nikos; PERRAKI, Maria; CHRISTOPHYLAKIS, Charalambos et al.Journal of clinical oncology. 2006, Vol 24, Num 23, pp 3756-3762, issn 0732-183X, 7 p.Article